Aging-driven decomposition in zolpidem hemitartrate hemihydrate and the single-crystal structure of its decomposition products

Journal of Pharmaceutical Sciences

Volumn 100, Issue 4, 2011, Pages 1377-1386

  Vega, Daniel R ^a,b   Baggio, Ricardo ^a   Roca, Mariana ^c   Tombari, Dora ^c  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^c Gador SA   (Argentina)

Author keywords

Crystal structure; Hydrate; Polymorphism; Solid state stability; Thermal analysis

Indexed keywords

BASE; ZOLPIDEM TARTRATE; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE; ZOLPIDEM;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DECOMPOSITION; DRUG STABILITY; DRUG STRUCTURE; ROOM TEMPERATURE; TEMPERATURE; X RAY POWDER DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY; POWDER DIFFRACTION; X RAY DIFFRACTION;

DRUG STABILITY; GABA-A RECEPTOR AGONISTS; HYPNOTICS AND SEDATIVES; MODELS, MOLECULAR; POWDER DIFFRACTION; PYRIDINES; X-RAY DIFFRACTION;

EID: 79951906999     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22358     Document Type: Article

References (15)

1. Arbilla S, Depoortere H, George P, Langer SZ. 1985. Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rat. Naunyn Schmiedebergs Arch Pharmacol 330(3):248-251.
2. Debruyne D, Lacotte J, De HuraultLigny B, Moulin M. 1991. Determination of zolpidem and zopiclone in serum by capillary column gas chromatography. J Pharm Sci 80(1):71-74.
3. Trapani G, Latrofa A, Franco M, Pantaleo MR, Sanna E, Massa F, Tuveri F, Liso G. 2000. Complexation of zolpidem with 2-hydroxypropyl-β-, methyl-β-, and 2-hydroxypropyl-γ-cyclodextrin: Effect on aqueous solubility, dissolution rate, and ataxic activity in rat. J Pharm Sci 89(11):1443-1451.
4. Halasz I, Dinnebier RE. 2010. Structural and thermal characterization of zolpidem hemitartrate hemihydrate (form E) and its decomposition products by laboratory X-ray powder diffraction. J Pharm Sci 99(2):871-878.
5. Aronhime J, Leonov D. 2006. Zolpidem hemitartrate solvate. Patent EP1541146 B1.
6. Banerjee R, Bhatt PM, Ravindra NV, Desiraju GR. 2005. Solid-state architecture of saccharin salts of some diamines. Cryst Growth Design 5(6):2299-2309.
7. George P, Rossey G, Depoortere H, Mompon B, Allen J, Wick A. 1988. Zolpidem and related compounds: Synthesis, physical properties and structure-activity relationships in Imidazopyridines. In Sleep disorders: A novel experimental and therapeutic approach; Sauvanet JP, Langer SZ, Morselli, Eds. New York: PL. Raven Press Ltd., pp 11-24.
8. Ettema GJB, Lemmens JM, Peters THA, Picha F. 2000. Zolpidem salts, Patent WO00/58310; and Ettema GJB, Lemmens JM, Peters THA, Picha F. 2001. Patent US6242460 B1.
9. Bruker 2002. SMART-NT V5.624. Data Collection Software; SAINT-NT V6.22a (Including SADABS). Data Reduction Software. Siemens Analytical X-ray Instruments Inc., Madison, Wisconsin.
10. Sheldrick GM. 2008. A short history of SHELX. Acta Cryst. A64, pp 112-122.
11. Spek AL. 2003. Single-crystal structure validation with the program PLATON. J Appl Crystallogr 36: 7-13.
12. Bernstein J, Davis RE, Shimoni L, Chang NL. 1995. Patterns in hydrogen bonding: Functionality and graph set analysis in crystals. Angew Chem Int (Ed Eng) 34: 1555-1573.
13. Lawecka M, Kosmacińska B., Glice M, Korczak K. 2006. The influence of storage conditions on the polymorphic stability of zolpidem tartrate hydrate. J Therm Anal Calorimetry 83(3): 583-585.
14. Janiak C. 2000. A critical account on π stacking in metal complexes with aromatic nitrogen-containing ligands. J Chem Soc Dalton Trans 3885-3898.
15. Allen FH. 2002. The Cambridge structural database: A quarter of a million crystal structures and rising. Acta Cryst B58: 380-388.